Carl Leslie North

This inventor holds 6 USPTO granted patents and 10 published patent applications and 6 EPO patents. Top assignees: Padlock Therapeutics, Inc., Cardioxyl Pharmaceuticals, Inc., Chroma Therapeutics Limited. Active years: 2017-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carl Leslie North. Retrieved from https://idiyas.com/inventor/carl-leslie-north

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 10)

% Patents Active = 83.3

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 13(Granted Patents)

Company Filing History:

3 out of 6

Padlock Therapeutics, Inc.

patents

2 out of 37

Cardioxyl Pharmaceuticals, Inc.

patents

1 out of 19

Chroma Therapeutics Limited

patents

4. 1 out of 3,801

Johns Hopkins University

patents

where one patent can have more than one assignee

Years Active: 2017-2021

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11026937 - Heteroaryl inhibitors of PAD4 (2021-06-08),

2. 10723704 - Pyrazolone derivatives as nitroxyl donors (2020-07-28),

3. 10703741 - Covalent inhibitors of PAD4 (2020-07-07),

4. 9963448 - Bicyclic inhibitors of PAD4 (2018-05-08),

5. 9682938 - Pyrazolone derivatives as nitroxyl donors (2017-06-20),

6. 9604940 - 2-aminopyrazine derivatives as CSF-1R kinase inhibitors (2017-03-28),

Title: The Innovative Contributions of Carl Leslie North

Introduction

Carl Leslie North is a notable inventor based in Abingdon, GB, recognized for his significant contributions to the field of pharmaceuticals. With a total of six patents to his name, North has focused on developing innovative compounds that address critical health issues.

Latest Patents

Among his latest patents, North has developed "Heteroaryl inhibitors of PAD4," which provides compounds useful as inhibitors of PAD4, compositions thereof, and methods for treating PAD4-related disorders. Another significant patent is for "Pyrazolone derivatives as nitroxyl donors," which offers pyrazolone derivative compounds, pharmaceutical compositions, kits, and methods for treating heart failure.

Career Highlights

Throughout his career, Carl Leslie North has worked with prominent companies such as Padlock Therapeutics, Inc. and Cardioxyl Pharmaceuticals, Inc. His work has been instrumental in advancing therapeutic options for patients suffering from various conditions.

Collaborations

North has collaborated with talented individuals in the field, including Rajesh Devraj and Gnanasambandam Kumaravel, contributing to the success of his innovative projects.

Conclusion

Carl Leslie North's work exemplifies the spirit of innovation in the pharmaceutical industry, with his patents paving the way for new treatments and therapies. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.